Leading the Way in Life Science Technologies

GEN Exclusives

More »
ANVISA - Related Content
  • Columns: Biosimilars in Brazil
    Revised ANVISA guidelines encourage development of biologics and biosimilars in Brazil in response to an increasing demand for development there.

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »